WSE:KME

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Kancelaria Medius S.A. engages in the receivables management business in Poland. More Details


Snowflake Analysis

Slightly overvalued with imperfect balance sheet.

Share Price & News

How has Kancelaria Medius's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: KME is more volatile than 90% of Polish stocks over the past 3 months, typically moving +/- 26% a week.

Volatility Over Time: KME's weekly volatility has increased from 21% to 26% over the past year.


Market Performance


7 Day Return

19.0%

KME

-5.1%

PL Commercial Services

-0.5%

PL Market


1 Year Return

-81.1%

KME

31.1%

PL Commercial Services

-6.5%

PL Market

Return vs Industry: KME underperformed the Polish Commercial Services industry which returned 31.6% over the past year.

Return vs Market: KME underperformed the Polish Market which returned -5.4% over the past year.


Shareholder returns

KMEIndustryMarket
7 Day19.0%-5.1%-0.5%
30 Day65.3%-2.0%17.2%
90 Dayn/a1.4%3.0%
1 Year-81.1%-81.1%34.4%31.1%-5.7%-6.5%
3 Year-94.5%-94.5%26.8%21.1%-16.7%-21.8%
5 Year-61.0%-61.0%47.9%38.3%3.2%-8.4%

Long-Term Price Volatility Vs. Market

How volatile is Kancelaria Medius's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Kancelaria Medius undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: KME (PLN1.19) is trading below our estimate of fair value (PLN4.11)

Significantly Below Fair Value: KME is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: KME is unprofitable, so we can't compare its PE Ratio to the PL Commercial Services industry average.

PE vs Market: KME is unprofitable, so we can't compare its PE Ratio to the Polish market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate KME's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: KME is overvalued based on its PB Ratio (23.2x) compared to the PL Commercial Services industry average (1.1x).


Next Steps

Future Growth

How is Kancelaria Medius forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

30.5%

Forecasted Commercial Services industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Kancelaria Medius has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Kancelaria Medius performed over the past 5 years?

-31.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: KME is currently unprofitable.

Growing Profit Margin: KME is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: KME is unprofitable, and losses have increased over the past 5 years at a rate of 31.7% per year.

Accelerating Growth: Unable to compare KME's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: KME is unprofitable, making it difficult to compare its past year earnings growth to the Commercial Services industry (55.1%).


Return on Equity

High ROE: KME has a negative Return on Equity (-7968.27%), as it is currently unprofitable.


Next Steps

Financial Health

How is Kancelaria Medius's financial position?


Financial Position Analysis

Short Term Liabilities: KME's short term assets (PLN114.9M) exceed its short term liabilities (PLN41.9M).

Long Term Liabilities: KME's short term assets (PLN114.9M) exceed its long term liabilities (PLN87.1M).


Debt to Equity History and Analysis

Debt Level: KME's debt to equity ratio (12188.9%) is considered high.

Reducing Debt: KME's debt to equity ratio has increased from 119.4% to 12188.9% over the past 5 years.

Debt Coverage: KME's debt is not well covered by operating cash flow (17.4%).

Interest Coverage: Insufficient data to determine if KME's interest payments on its debt are well covered by EBIT.


Balance Sheet


Next Steps

Dividend

What is Kancelaria Medius's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate KME's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate KME's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if KME's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if KME's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of KME's dividend in 3 years as they are not forecast to pay a notable one for the Polish market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

0.4yrs

Average board tenure


CEO

Przemyslaw Dabrowski

0.33

Tenure

Mr. Przemyslaw Dabrowski serves as the Chief Financial Officer of Powszechny Zaklad Ubezpieczen na Zycie S.A. He serves as the Chairman of the Board at Kancelaria Medius S.A. since July 2020. Mr. Dabrowski...


Board Members

NamePositionTenureCompensationOwnership
Tomasz Luczynski
Chairman of The Supervisory Board0.42yrno datano data
Wlodzimierz Bielinski
Vice Chairman of the Supervisory Board0.42yrno datano data
Grzegorz Pilch
Member of The Supervisory Board0.42yrno datano data
Janusz Bielawski
Member of The Supervisory Board0.42yrno datano data
Jakub Rajchman
Member of The Supervisory Board0.42yrno datano data

0.4yrs

Average Tenure

Experienced Board: KME's board of directors are not considered experienced ( 0.4 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Kancelaria Medius S.A.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Kancelaria Medius S.A.
  • Ticker: KME
  • Exchange: WSE
  • Founded:
  • Industry: Diversified Support Services
  • Sector: Commercial Services
  • Market Cap: zł17.352m
  • Shares outstanding: 14.58m
  • Website: https://www.kancelariamedius.pl

Number of Employees


Location

  • Kancelaria Medius S.A.
  • ul. Babinskiego 69
  • Kraków
  • 30-393
  • Poland

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
KMEWSE (Warsaw Stock Exchange)YesCommon Bearer SharesPLPLNAug 2012

Biography

Kancelaria Medius S.A. engages in the receivables management business in Poland. It offers debt portfolios purchasing, debt collection management, and legal services, as well as manages claims secured by a...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/11/30 18:05
End of Day Share Price2020/11/30 00:00
Earnings2020/09/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.